fitness
Shilpa Medicare gets USFDA nod for cancer treatment injection
Shares of Shilpa Medicare were trading 3.80 per cent up at Rs 398.65 apiece on BSE.
from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2SvX9PB
via
IFTTT
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment